IRadimed Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (25)

View All

Latest Posts

About This Stock More About This Stock
MRI Device Maker's Earnings Come In At High End Of Forecasts
Article By: The Life Sciences Report
Wednesday, August 3, 2022 12:19 PM EDT
After its earnings beat, improved margins and disciplined cost control measures, IRadimed keeps its buy rating and its price target has been raised to $42/share (up from $40).
In this article: IRMD
Read
2 Small-Cap Healthcare Stocks To Buy And Hold For Years
Article By: StockNews
Friday, September 24, 2021 1:28 PM EDT
The rapid adoption of technologies and a push to develop therapeutics to serve an aging population have catalyzed the healthcare sector’s growth.
In this article: IRMD, SMLR
Read
Best ETFs & Stocks From The Top Sector Of Q3
Article By: Sweta Killa
Monday, October 1, 2018 11:11 PM EDT
Healthcare was the best-performing sector of the third quarter, jumping 14.1% — its highest quarterly gain since the first quarter of 2013.
In this article: ENDP, FXH, IHF, IYH, IRMD, RARX, IDXG, ARKG, CSBR, XLV
Read
Iradimed: Chart Of The Day
Article By: Jim Van Meerten
Monday, July 2, 2018 5:39 PM EDT
The chart of the day belongs to Iradimed (IRMD). Since the Trend Spotter signaled a buy in 3/21 the stock gained 47.04%.
In this article: IRMD
Read
Upcoming Monitoring System Makes Iradimed A Good Mid-Term Investment
Article By: KKD Healthcare Analytics
Tuesday, June 13, 2017 10:07 AM EDT
For the second quarter of the year, iRadimed Corp. expects its revenue to be in the range of $5.4 million to $5.5 million while its first quarter revenue stood at $5.2 million.
In this article: IRMD
Read
All Posts

Latest Tweets for $IRMD

No tweets yet!

PARTNER HEADLINES